Delay in the world’s poorest facial vaccine through the Caucasus program World news

Some of the world’s poorest countries have been warned that they will be vaccinated with the Covid 19 vaccine through the UN-backed Caucasus program after a double blow of technical difficulties at a South Korean manufacturing plant and difficulties in obtaining an export license from the Indian government. Expect delays in delivery. , UNICEF said.

The 90 million doses of the Oxford / AstraZeneca vaccine could be affected by the twins, which emerged on Wednesday after news that India had temporarily suspended vaccine exports amid a rise in new cases.

Some of the countries expecting food from Kovacs next week include South Sudan, Mauritius, Iraq, Bosnia and Herzegovina and Yemen, where the government Announced on Wednesday A health emergency such as a second wave of infection is over. UNICEF said Thursday it was not immediately clear how their supplies would be affected.

“The Quix facility has informed the participants that they will allocate different parts of it [Oxford/AstraZeneca] Vaccines manufactured in South Korea will ship in smaller quantities than planned in March.

“Given the current global supply challenges, this is because of the challenges the company faces in rapidly increasing supply for these early supplies and improving the production process,” AstraZeneca reported. [Covax] The facility will create a volume of delays between April and May.

The United Nations says it is working to confirm whether the serum institute of India, the largest supplier to Kovacs, has been banned from exporting food, but says It is understood that obtaining an export license is a blow.

“We believe that the supply of COD-19 vaccines to low-income economies participating in the COMEX facility may be one of the reasons for obtaining export licenses for additional quantities of COVID 19 vaccines developed by the Serum Institute of India. There will be potential delays after the blow. In March and April, “said a UNICEF spokesman.

Quakes – a partnership between UNICEF, the World Health Organization, the Vaccine Alliance GVI and the Anti-Epidemiology Prevention Innovation, using rich countries to procure vaccines for poor and middle-income countries.

It has so far distributed 28 million doses of the Oxford / AstraZeneca vaccine developed by the Serum Institute, and said it expects 40 million additional doses to be available in March and up to 50 million doses in April. ۔


Leave a Reply

Your email address will not be published. Required fields are marked *